These observations suggest that RASSF1A acts as a tumor suppressor in ERα+ breast epithelial cells, in part through the regulation of ERα expression and activity, suppression of ERα-mediated expression of oncogenes as well as through the repression of signaling pathways that are important for E2-independence [5]. Here, ESR1 is linked to neoplasm.